191 related articles for article (PubMed ID: 20727186)
41. Inhibition of Polo-Like Kinase 1 by BI2536 Reverses the Multidrug Resistance of Human Hepatoma Cells In Vitro and In Vivo.
Li HY; Luo F; Li XY; Fu XF; He JF; Tian YZ; Zhu JJ; Chu XY; Zhao HL
Anticancer Agents Med Chem; 2019; 19(6):740-749. PubMed ID: 30836927
[TBL] [Abstract][Full Text] [Related]
42. EGF reverses multi-drug resistance via the p-ERK pathway in HepG2/ADM and SMMC7721/ADM hepatocellular carcinoma models.
Yan F; Bai LP; Gao H; Zhu CM; Lin L; Kang XP
Asian Pac J Cancer Prev; 2014; 15(6):2619-23. PubMed ID: 24761873
[TBL] [Abstract][Full Text] [Related]
43. Methylation of Ras association domain family protein 1, isoform A correlated with proliferation and drug resistance in hepatocellular carcinoma cell line SMMC-7721.
Zhao QZ; Dou KF
J Gastroenterol Hepatol; 2007 May; 22(5):683-9. PubMed ID: 17444856
[TBL] [Abstract][Full Text] [Related]
44. Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture.
Cui J; Nan KJ; Tian T; Guo YH; Zhao N; Wang L
World J Gastroenterol; 2007 Nov; 13(41):5432-9. PubMed ID: 17907285
[TBL] [Abstract][Full Text] [Related]
45. Arsenic trioxide inhibits the growth of adriamycin resistant osteosarcoma cells through inducing apoptosis.
Zhao H; Guo W; Peng C; Ji T; Lu X
Mol Biol Rep; 2010 Jun; 37(5):2509-15. PubMed ID: 19701692
[TBL] [Abstract][Full Text] [Related]
46. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
Li G; Dong S; Qu J; Sun Z; Huang Z; Ye L; Liang H; Ai X; Zhang W; Chen X
Liver Int; 2010 Apr; 30(4):585-92. PubMed ID: 19780956
[TBL] [Abstract][Full Text] [Related]
47. Tamoxifen reverses the multi-drug-resistance of an established human cholangiocarcinoma cell line in combined chemotherapeutics.
Liu ZH; Ma YL; He YP; Zhang P; Zhou YK; Qin H
Mol Biol Rep; 2011 Mar; 38(3):1769-75. PubMed ID: 20835928
[TBL] [Abstract][Full Text] [Related]
48. Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines.
Qian JQ; Sun P; Pan ZY; Fang ZZ
Int J Clin Exp Pathol; 2015; 8(9):11934-44. PubMed ID: 26617951
[TBL] [Abstract][Full Text] [Related]
49. Platycodin D induces apoptosis and triggers ERK- and JNK-mediated autophagy in human hepatocellular carcinoma BEL-7402 cells.
Li T; Xu XH; Tang ZH; Wang YF; Leung CH; Ma DL; Chen XP; Wang YT; Chen Y; Lu JJ
Acta Pharmacol Sin; 2015 Dec; 36(12):1503-13. PubMed ID: 26592509
[TBL] [Abstract][Full Text] [Related]
50. Reversing resistance of multidrug-resistant hepatic carcinoma cells with parthenolide.
Liu D; Liu Y; Liu M; Ran L; Li Y
Future Oncol; 2013 Apr; 9(4):595-604. PubMed ID: 23560381
[TBL] [Abstract][Full Text] [Related]
51. Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line.
Yang JX; Luo Y; Qiu HM; Tang WX
Saudi Med J; 2009 Jan; 30(1):35-40. PubMed ID: 19139770
[TBL] [Abstract][Full Text] [Related]
52. Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line.
Zaja R; Caminada D; Loncar J; Fent K; Smital T
Toxicol Appl Pharmacol; 2008 Mar; 227(2):207-18. PubMed ID: 18076962
[TBL] [Abstract][Full Text] [Related]
53. The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line.
Huang M; Liu G
Cancer Lett; 1999 Jan; 135(1):97-105. PubMed ID: 10077227
[TBL] [Abstract][Full Text] [Related]
54. Establishment of a cisplatin-induced multidrug resistance cell line SK-Hep1/DDP.
Zhou Y; Ling XL
Chin J Cancer; 2010 Feb; 29(2):167-71. PubMed ID: 20109345
[TBL] [Abstract][Full Text] [Related]
55. Reversal effect of 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.
Huang HY; Niu JL; Zhao LM; Lu YH
Phytomedicine; 2011 Sep; 18(12):1086-92. PubMed ID: 21596545
[TBL] [Abstract][Full Text] [Related]
56. Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines.
Liu Z; Qiu M; Tang QL; Liu M; Lang N; Bi F
Chin J Cancer; 2010 Jul; 29(7):661-7. PubMed ID: 20591218
[TBL] [Abstract][Full Text] [Related]
57. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
Kim WJ; Kakehi Y; Yoshida O
Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
[TBL] [Abstract][Full Text] [Related]
58. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
59. [Reversal of stemness in multidrug-resistant hepatocellular carcinoma cells by SIS3].
Yan W; Wen T; Lin S; Liu Z; Yang W; Wu G
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):731-5. PubMed ID: 26813590
[TBL] [Abstract][Full Text] [Related]
60. Rosmarinic Acid Combined with Adriamycin Induces Apoptosis by Triggering Mitochondria-Mediated Signaling Pathway in HepG2 and Bel-7402 Cells.
Huang Y; Cai Y; Huang R; Zheng X
Med Sci Monit; 2018 Nov; 24():7898-7908. PubMed ID: 30391993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
